INTERVIEW

Immutep (ASX:IMM) reports first subject dosed in autoimmune disease study
19 Aug 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses progress with the company's IMP761 drug, which is potentially active in more than 90% of autoimmune diseases.

Blue dinosaurs and oat milk: CEO Alex Aleksic discusses Forbidden Foods
16 Aug 2024 - Forbidden Foods Limited (ASX:FFF) CEO and Managing Director Alex Aleksic provides an introduction to the company, discussing its recent acquisition of Good Oats.

America's largest lithium resource: A conversation with Jindalee Lithium CEO Ian Rodger
12 Aug 2024 - Jindalee Lithium Limited (ASX:JLL) CEO Ian Rodger provides an overview of the company, discussing the McDermitt project, progress on the PFS and grant funding.

Copper-gold in Utah and lithium in Brazil
06 Aug 2024 - Alderan Resources Limited (ASX:AL8) Managing Director Scott Caithness discusses the company's exploration targets and progress.

Diagnosing autism and ADHD from a smartphone
05 Aug 2024 - BlinkLab Limited (ASX:BB1) Non-Executive Chairman Brian Leedman discusses transforming smartphones into diagnostic tools.

High-grade gold intercepts and NZX listing: An interview with Santana Minerals' Sam Smith
01 Aug 2024 - Santana Minerals Limited (ASX:SMI) Executive Director Sam Smith provides an update on the company, discussing the latest high-grade drill results from the Rise and Shine deposit and commenting on the company's recent listing on the New Zealand Stock Exchange.

2024 Noosa Mining Conference: Equity Events
31 07 2024 - Amy Dickinson - Event Manager - Equity Events is a Brisbane based company which specialises in organising investment events for the mining, energy, exploration and industrial sectors.

Fed policy, tech stocks and small caps: A discussion with Jeffrey Schulze
30 Jul 2024 - Jeffrey Schulze, Managing Director of ClearBridge Investments, shares insights on the US markets, discussing interest rates, catalysts for the rotation out of tech and the Magnificent Seven and the durability of the move into small caps.

Clinical trials in cancer and autoimmune diseases: Immutep's CEO Marc Voigt provides an update
30 Jul 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses Phase III design for a trial in non-small cell lung cancer, positive results in head and neck cancer, and clearance for a Phase I study in autoimmune diseases.

Noosa Mining Investor Conference, July 2024 - Ardea Resources (ASX:ARL)
30 Jul 2024 - Andrew Penkethman - CEO & Managing Director - Ardea Resources (ASX:ARL) is an ASX-listed nickel resources company, with a large portfolio of 100%-controlled West Australian-based projects.